Skip to main content
logo
Rapid Micro Biosystems, Inc. (RPID)
NASDAQ: RPID · Real-Time Price · USD
4.100
-0.240 (-5.53%)
At close: Jul 25, 2025, 4:00 PM
4.080
-0.020 (-0.49%)
After-hours: Jul 25, 2025, 4:19 PM EDT

Rapid Micro Biosystems Revenue

Rapid Micro Biosystems had revenue of $7.21M in the quarter ending March 31, 2025, with 28.41% growth. This brings the company's revenue in the last twelve months to $29.65M, up 28.36% year-over-year. In the year 2024, Rapid Micro Biosystems had annual revenue of $28.05M with 24.57% growth.

Revenue (ttm)
$29.65M
Revenue Growth
+28.36%
P/S Ratio
6.41
Revenue / Employee
$181,871
Employees
163
Market Cap
179.70M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202428.05M5.53M24.57%
Dec 31, 202322.52M5.39M31.44%
Dec 31, 202217.13M-6.10M-26.25%
Dec 31, 202123.23M7.15M44.50%
Dec 31, 202016.08M-435.00K-2.63%
Dec 31, 2019 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group410.06B
Johnson & Johnson90.63B
Merck & Co.63.92B
AbbVie57.37B
Novartis AG55.19B
AstraZeneca54.98B
Eli Lilly and Company49.00B
Novo Nordisk43.92B
Revenue Rankings

RPID News

More News